Abstract
HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.brachy.2017.04.038
Copy DOIJournal: Brachytherapy | Publication Date: May 1, 2017 |
Citations: 1 |
HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials
Join us for a 30 min session where you can share your feedback and ask us any queries you have